Healthcare ColDays, a key event devoted to the pharmaceutical cold chain, was held in Lyon, France, from November 22 to 23, and was a resounding success. Organized by the French refrigeration association Association Francaise du Froid (AFF) in partnership with the International Society for Pharmaceutical Engineering (ISPE) and the International Institute of Refrigeration (IIR), the event attracted 58 exhibitors and 200 participants.
During the opening session, Gerald Cavalier, president of AFF, welcomed the participants and gave background on the aims of the event, highlighting the fact that many health products such as vaccines, insulin, labile blood products, biotechnology products, tissue, and organs are heat-sensitive, and changes in their storage temperature can render them unusable, ineffective, or even dangerous. Among the top ten medicines sold across the world, only one has no specific temperature require ments. The temperature control of these healthcare products throughout the distribution chain is thus vital because of the health and economic factors involved. Gerald Cavalier presented several key figures and highlighted that 4.7 billion vaccines are administered every year, and eight out of ten drugs are temperature sensitive.